Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annemie Prové

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|October 4, 2016
Neratinib for the treatment of breast cancerAnnemie Prové, Luc Dirix
Current Opinion in Oncology|September 22, 2006
Inflammatory breast cancer: current understandingLuc Y Dirix, Peter Van Dam, Annemie Prové, et al.
Breast Cancer Research and Treatment|February 8, 2022
Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancerLuc Y Dirix, Steffi Oeyen, Andy Buys, et al.
Clinical Breast Cancer|February 14, 2008
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancerRobert Paridaens, Luc Dirix, Herlinde Dumez, et al.
Breast Cancer Research and Treatment|April 9, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancerLuc Dirix, Andy Buys, Steffy Oeyen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|October 4, 2016
Neratinib for the treatment of breast cancerAnnemie Prové, Luc Dirix
Current Opinion in Oncology|September 22, 2006
Inflammatory breast cancer: current understandingLuc Y Dirix, Peter Van Dam, Annemie Prové, et al.
Breast Cancer Research and Treatment|February 8, 2022
Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancerLuc Y Dirix, Steffi Oeyen, Andy Buys, et al.
Clinical Breast Cancer|February 14, 2008
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancerRobert Paridaens, Luc Dirix, Herlinde Dumez, et al.
Breast Cancer Research and Treatment|April 9, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancerLuc Dirix, Andy Buys, Steffy Oeyen, et al.
Pageof 1